
Jim Cramer Discusses Various Stock Market Insights and Company Valuations
Jim Cramer has offered diverse insights on the stock market, including his reluctance to recommend Pfizer despite its dividend, defending a struggling tech giant, and highlighting future earnings projections for Oracle and Meta's entry into the neocloud business.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Low (19/100)Sources
Cramer defends a struggling tech giant and says another stock could soon be a buy
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
Read full article →‘It Kills Me to Say That’: Cramer Won’t Recommend Pfizer, Even With Its 7% Dividend
Read full article →Coverage Timeline
Related Stories

Amazon's First Sale Receipt Goes Viral, Drawing Reactions from Bezos and Musk
just now
Veritas University Abuja Launches N1.3bn Tech and Entrepreneurship Hub
just now

Your Password Could Be The Weakest Link: 5 Mistakes That Put Your Accounts at Risk
19m ago
Iranian Girls Die by Suicide, Honor Killing After Sextortion Channel Leak
22m ago